TY - JOUR
T1 - Microbiome profiling reveals gut bacterial species associated with rapid lung function decline in people with HIV
AU - Bai, Xiangning
AU - Raju, Sajan C
AU - Knudsen, Andreas Dehlbæk
AU - Thudium, Rebekka Faber
AU - Arentoft, Nicoline Stender
AU - Gelpi, Marco
AU - Heidari, Safura-Luise
AU - Kunisaki, Ken M
AU - Kristiansen, Karsten
AU - Hov, Johannes Roksund
AU - Nielsen, Susanne Dam
AU - Trøseid, Marius
N1 - Copyright © 2025 Bai, Raju, Knudsen, Thudium, Arentoft, Gelpi, Heidari, Kunisaki, Kristiansen, Hov, Nielsen and Trøseid.
PY - 2025
Y1 - 2025
N2 - BACKGROUND: People with HIV (PWH) have an increased risk of pulmonary comorbidities compared to people without HIV. The gut microbiome regulates host immunity and is altered in PWH. This study aims to determine potential associations between gut microbiome, lung function decline, and airflow limitation in PWH.METHODS: PWH from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study with available lung function testing and microbiome data were included (n=385). The gut microbiome was characterized using shotgun metagenomic sequencing. Associations between gut microbiome, rapid lung function decline, and airflow limitation were analysed in multivariable logistic regressions adjusted for traditional and HIV-associated risk factors for lung disease.RESULTS: Several bacterial species were significantly enriched in PWH with rapid lung function decline, including opportunistic pathogenic bacterial species Bacteroides coprophilus, Klebsiella michiganensis, and Clostridium perfringens. A gut microbial dysbiosis index based on compositional changes was associated with rapid lung function decline (adjusted odds ratio (aOR) 1.18, 95% confidence interval (CI) [1.11-1.27], p<0.001), and airflow limitation (aOR 1.16, 95% CI [1.04-1.29], p=0.007) in adjusted multivariable logistic regression analyses.CONCLUSION: Associations between the gut dysbiosis index and rapid lung function decline and airflow limitation suggest a potential role of certain gut bacterial species in the pathogenesis of pulmonary comorbidities in PWH.
AB - BACKGROUND: People with HIV (PWH) have an increased risk of pulmonary comorbidities compared to people without HIV. The gut microbiome regulates host immunity and is altered in PWH. This study aims to determine potential associations between gut microbiome, lung function decline, and airflow limitation in PWH.METHODS: PWH from the Copenhagen Comorbidity in HIV Infection (COCOMO) Study with available lung function testing and microbiome data were included (n=385). The gut microbiome was characterized using shotgun metagenomic sequencing. Associations between gut microbiome, rapid lung function decline, and airflow limitation were analysed in multivariable logistic regressions adjusted for traditional and HIV-associated risk factors for lung disease.RESULTS: Several bacterial species were significantly enriched in PWH with rapid lung function decline, including opportunistic pathogenic bacterial species Bacteroides coprophilus, Klebsiella michiganensis, and Clostridium perfringens. A gut microbial dysbiosis index based on compositional changes was associated with rapid lung function decline (adjusted odds ratio (aOR) 1.18, 95% confidence interval (CI) [1.11-1.27], p<0.001), and airflow limitation (aOR 1.16, 95% CI [1.04-1.29], p=0.007) in adjusted multivariable logistic regression analyses.CONCLUSION: Associations between the gut dysbiosis index and rapid lung function decline and airflow limitation suggest a potential role of certain gut bacterial species in the pathogenesis of pulmonary comorbidities in PWH.
KW - Humans
KW - Gastrointestinal Microbiome
KW - Male
KW - Female
KW - HIV Infections/microbiology
KW - Middle Aged
KW - Dysbiosis
KW - Lung/physiopathology
KW - Bacteria/genetics
KW - Adult
KW - Lung Diseases/microbiology
KW - Respiratory Function Tests
KW - Aged
KW - lung function decline
KW - gut microbiome
KW - spirometry
KW - HIV
KW - airflow limitation
KW - pulmonary comorbidity
UR - http://www.scopus.com/inward/record.url?scp=105008915849&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2025.1555441
DO - 10.3389/fimmu.2025.1555441
M3 - Journal article
C2 - 40557154
SN - 1664-3224
VL - 16
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 1555441
ER -